Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study

被引：0
作者：
Danni Li
Fangying Huang
Yingchun Zhao
Peter W. Villata
Timothy J. Griffin
Lin Zhang
Ling Li
Fang Yu
机构：
[1] University of Minnesota,Department of Laboratory Medicine and Pathology
[2] University of Minnesota,Masonic Cancer Center
[3] University of Minnesota,Department of Biochemistry, Molecular Biology, and Biophysics
[4] University of Minnesota,Department of Biostatistics
[5] University of Minnesota,Department of Experimental and Clinical Pharmacology
[6] University of Minnesota,School of Nursing
来源：
Clinical Proteomics | 2018年 / 15卷
关键词：
Alzheimer’s disease; Plasma lipoproteins; Targeted proteomics; Complement C3; Very low-density lipoprotein (VLDL); Intermediate density lipoprotein (IDL); Low density lipoprotein (LDL); High-density lipoprotein (HDL); Biomarker; Diagnosis; Selected reaction monitoring (SRM);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 107 条
[1]  
Albert MS(2011)The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimer’s Dement 7 270-279
[2]  
DeKosky ST(2011)Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimer’s Dement 7 280-292
[3]  
Dickson D(2011)Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging Neurology 76 1091-1098
[4]  
Sperling RA(2016)Plasma apolipoprotein J as a potential biomarker for Alzheimer’s disease: Australian Imaging, Biomarkers and Lifestyle study of aging Alzheimers Dement (Amst) 3 18-26
[5]  
Aisen PS(2010)Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease Arch Gen Psychiatry 67 739-748
[6]  
Beckett LA(2012)Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals PLoS ONE 7 e34078-311
[7]  
Gupta VB(2015)Plasma levels of apolipoprotein E and risk of dementia in the general population Ann Neurol 77 301-1326
[8]  
Laws SM(2011)Plasma clusterin and the risk of Alzheimer disease JAMA 305 1322-756
[9]  
Villemagne VL(2007)Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J Clin Invest 117 746-1530
[10]  
Gupta VB(2015)Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity J Lipid Res 56 1519-917
12345678910